Elacestrant,SAR439859,Giredestrant
Radius Pharmaceuticals,menarini,sanofi,roche
[' fulv']
 highlights inevitable endo resistance...seems this is happening earlier post-cdk fulvestrant although active against esr1....it is less so than wt numerical improvement in esr1 patients raises the ? - is monotherapy the best strategy? #esmo22 
Med Onc, Director of Breast & GYN Research Program @ Sarah Cannon Research Institute #bcsm #gyncsm #WomenInMedicine USAF Wife, Mom to 2 girls, tweets are mine.